Search Results for keywords:"committee renewal"

Found 5 results

Search Results: keywords:"committee renewal"

💰 Only
Oldest Newest
  • 2024-31363 — Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal
    Type:Notice
    Citation:89 FR 107148
    Reading Time:about 3 minutes

    The Food and Drug Administration (FDA) has announced the renewal of the Dermatologic and Ophthalmic Drugs Advisory Committee, which will now operate until October 7, 2026. The committee provides expert advice on the safety and effectiveness of drugs used to treat skin and eye conditions, ensuring they are safe for human use. The committee is made up of professionals from various medical fields, including dermatology and ophthalmology, who are selected by the FDA Commissioner. This renewal highlights the FDA's commitment to maintaining expert oversight of drugs within this category.

    Simple Explanation

    The FDA is keeping a special group of doctors and experts together until 2026 to make sure that medicines for skin and eyes are safe for people to use.

  • 2021-03239 — Advisory Committee; Technical Electronic Product Radiation Safety Standards Committee; Renewal
    Type:Notice
    Citation:86 FR 10108
    Reading Time:about 2 minutes

    The Food and Drug Administration (FDA) is renewing the Technical Electronic Product Radiation Safety Standards Committee for another two years, with the new charter effective until December 24, 2022. This committee provides advice to the FDA on setting standards for radiation emissions from electronic products. The committee includes 15 voting members, selected for their expertise in science or engineering related to radiation safety. The renewal is in the public interest to ensure the safeguarding of health and safety through proper regulatory standards.

    Simple Explanation

    The FDA is keeping a special team of experts for two more years to help make rules about how much radiation electronic gadgets can safely give off. This is done to make sure people are healthy and safe.

  • 2025-00357 — Advisory Committee; Antimicrobial Drugs Advisory Committee; Renewal
    Type:Notice
    Citation:90 FR 2008
    Reading Time:about 3 minutes

    The Food and Drug Administration (FDA) has renewed the charter for the Antimicrobial Drugs Advisory Committee until October 7, 2026. This independent advisory group helps the FDA ensure that drugs used to treat infectious diseases are safe and effective. The committee includes 13 voting members with expertise in fields like infectious diseases and internal medicine. The renewal is considered important to support public interest and ensure continued expert advice on drug safety and effectiveness.

    Simple Explanation

    The FDA is keeping a special group of experts, called the Antimicrobial Drugs Advisory Committee, to help make sure that medicines for infections are safe and work well, and this group will continue to do their job until 2026.

  • 2021-02890 — Defense Programs Advisory Committee Renewal
    Type:Notice
    Citation:86 FR 9327
    Reading Time:about a minute or two

    The Department of Energy has announced the renewal of the Defense Programs Advisory Committee (DPAC) for another two years starting on February 8, 2021. This committee will advise and offer recommendations on managing the United States' nuclear deterrent. The renewal is considered critical for the department's operations and aligns with federal law requirements. The committee's activities will continue to follow the rules set by the Federal Advisory Committee Act.

    Simple Explanation

    The Department of Energy is keeping a special group of people together to help them take care of America's nuclear weapons for another two years. This group gives advice to make sure everything is safe and follows the rules, and everybody thinks it's really important for them to keep doing this job.

  • 2021-01739 — Healthcare Infection Control Practices Advisory Committee (HICPAC); Notice of Charter Renewal
    Type:Notice
    Citation:86 FR 7294
    Reading Time:about a minute or two

    The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services (HHS), announced the renewal of the charter for the Healthcare Infection Control Practices Advisory Committee. This committee's charter has been extended for two years, lasting until January 19, 2023. This notice was made in accordance with the Federal Advisory Committee Act. For more information, interested parties can contact Koo-Whang Chung at the CDC.

    Simple Explanation

    The CDC, which is part of the U.S. Health Department, has decided to keep a group of experts, called the Healthcare Infection Control Practices Advisory Committee, who help them stop germs from spreading, working for two more years. This means they will continue their important work until January 19, 2023.